Decision to list various medical devices

Hospital devices Decision

PHARMAC is pleased to announce the approval of individual medical devices agreements:

In summary, this will result in:

  • 209 products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 December 2017.
  • DHB saving estimated at $733,000 per annum on the purchase of these product based on current usage levels. The following table provides a summary of the listings and savings:




Number of products

Annual Impact on DHBs*


Single use instruments



Nil (Maintains current pricing)


Single use instruments



$1,000 cost


Single use instruments

Solo, Sterling


$10,000 saving


Medical thermometers 

Filac, Genius, Surgipack, Mon-a-therm


$40,000 saving


VTE prevention products

A-V Impulse, SDC, T.E.D


$680,000 saving


Medical thermometers



$2,000 saving

*assumes no change to current usage levels

  • DHB hospitals would continue to be able to choose which medical devices they purchase, however would need to use these agreements should they choose to purchase Amtech, Defries, Hallmark, Medtronic or Terumo products listed in the Pharmaceutical Schedule.  

Any changes to the original proposals?

The proposals were broadly approved as consulted on, except for the following:

  • The consultation noted that the Hallmark proposal would be cost neutral, however this will provide savings on delivery fees (for orders with a value of over $500)
  • Prices on three products in the Hallmark Agreement have been corrected (reduced to align with the current price).

Details of the decisions

In 2016 PHARMAC released requests for proposals (“RFPs”) for medical thermometers, VTE Prevention and single use instruments. The purpose of these RFPs was to secure national contracts for DHB hospitals to purchase from.

Medtronic, Terumo, Amtech, Defries and Hallmark’s proposals met the associated RFP requirements and PHARMAC has entered into agreements with them for supply of medical devices to be listed on the Pharmaceutical Schedule. This means that DHB hospitals must use the PHARMAC Agreement should they choose to use these products from 1 December 2017.

The list of products will be available on PHARMAC’s website from 1 December 2017, in both a PDF document and an Excel spreadsheet.

Educational services will be provided by all suppliers to DHB personnel on the appropriate use of their medical devices and this will be arranged in formats and at times agreed with individual DHBs.

The agreements are not exclusive. DHBs can continue to purchase other brands of medical thermometers, VTE Prevention products and single use instruments. We expect to consult on further provisional agreements with other suppliers in these categories over the next few months.

Feedback received

We appreciate all of the feedback that we received and acknowledge the time people took to respond. All consultation responses received by 25 October 2017 for Medtronic, 3 November 2017 for Terumo and 6 November 2017 for Amtech, Defries and Hallmark were considered in their entirety in making a decision to approve the provisional Agreements. Most responses were supportive of the proposals, and the following issues were raised in relation to specific aspects of each proposal:



Medical Thermometers and VTE Prevention: Medtronic

Request for full product list.

List provided

Clarification on the ongoing distribution arrangements of products due to Medtronic selling off some ranges.

Medtronic have sold off some product ranges to Cardinal Health these will continue to be supported by Medtronic during the transition period agreed between the two companies. The agreement would be novated from Medtronic to Cardinal Health following the transition period and DHBs will be notified accordingly.


Medical Thermometers: Terumo

Medical thermometers come in a variety of types and it would be beneficial to know these specifics in the Pharmaceutical Schedule.

The Pharmaceutical Schedule would be organised by the sub-category of medical thermometer.


Whether the devices had been evaluated for New Zealand’s specific requirements

Under national contracting PHARMAC evaluates proposed medical devices in light of mandatory regulatory information, previous sales to DHBs and reference sites.

A lack of details in the consultation.

Detailed information including confidential contract terms was provided to DHB Procurement Managers.

Request to be added to the mailing list for future consultations

Noted and added to mailing list

Single use instruments: Amtech, Defries and Hallmark  

Request for full product list


Potential listing for other suppliers

Noted that further listings are expected in the future

More information

If you have any questions about this decision, you can email us at or call our toll-free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.